Office of the Director, National Institutes of Health; Notice of Meeting

<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>Office of the Director, National Institutes of Health; Notice of Meeting</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Advisory Committee on Research on Women's Health. The meeting will be open to the public as a virtual meeting. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website ( <E T="03">http://videocast.nih.gov/</E> ). <EXTRACT> <E T="03">Name of Committee:</E> Advisory Committee on Research on Women's Health. <E T="03">Date:</E> April 7, 2026. <E T="03">Time:</E> 9:00 a.m. to 4:00 p.m. <E T="03">Agenda:</E> ORWH Director's Report, NIH Inclusion Report, NHLBI's Director's Report, Opening Remarks from NIH Director, Keynote Presentation on ORWH's Role in Transforming Research Gaps into Breakthroughs, and a panel discussion to commemorate 35 years of ORWH's impact on women's health research. <E T="03">Place:</E> National Institutes of Health, 9000 Rockville Pike, Building 31, Bethesda, MD 20892. <E T="03">Contact Person:</E> Lucia Hindorff, Ph.D., Health Science Administrator, Office on Research for Women's Health, Division of Program Coordination, Planning and Strategic Initiatives, National Institutes of Health, 6707 Democracy Boulevard, Bethesda, MD 20892, 240-271-1509, <E T="03">lucia.hindorff@nih.gov</E> . Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 21 days in advance of the meetings. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute's/Center's home page: <E T="03">https://orwh.od.nih.gov/,</E> where an agenda and any additional information for the meeting will be posted when available. <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: December 16, 2025.</DATED> <NAME>Margaret Vardanian,</NAME> Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-23321 Filed 12-18-25; 8:45 am]</FRDOC> </NOTICE>